Green Tomato Extract Prevents Bone Loss in Ovariectomized Rats, a Model of Osteoporosis.
Farida S NirmalaHyunjung LeeJi-Sun KimTae-Youl HaChang Hwa JungJiyun AhnPublished in: Nutrients (2020)
Although drug therapies are available for postmenopausal osteoporosis, these drugs are not free of side effects and long-term adherence to them are low. A safe and effective nutritional approach to counter postmenopausal osteoporosis is an important research goal. We fed ovariectomized (OVX) Sprague-Dawley rats a diet supplemented with 1% or 2% green tomato extract (GTE). After 12 weeks, micro-computed tomography scans revealed that GTE supplementation effectively prevented distal femur bone loss. This prevention was due to improved bone formation and suppressed bone resorption as observed by the regulation of osteoblast and osteoclast activities. GTE supplementation also improved bone formation through Bmp2-Smad 1/5/8-Runx2 signaling, while bone resorption was regulated by the receptor activator of nuclear factor kappa-B (RANKL)/osteoprogeterin (OPG) pathway. These results suggest that GTE supplementation prevents severe postmenopausal bone loss by maintaining the regulation of bone homeostasis in OVX rats. GTE as a diet supplement might be a potential novel alternative for the prevention of postmenopausal osteoporosis.
Keyphrases
- bone loss
- bone mineral density
- nuclear factor
- postmenopausal women
- computed tomography
- toll like receptor
- body composition
- physical activity
- oxidative stress
- weight loss
- magnetic resonance imaging
- mesenchymal stem cells
- anti inflammatory
- drug induced
- transforming growth factor
- epithelial mesenchymal transition
- contrast enhanced
- mouse model
- transcription factor
- immune response
- bone regeneration
- magnetic resonance
- type diabetes
- risk assessment
- human health
- signaling pathway
- soft tissue
- adipose tissue
- breast cancer risk